Cyclopentobarbital: Difference between revisions
Content deleted Content added
Updating {{drugbox}} (no changed fields - added verified revid - updated 'UNII_Ref', 'ChemSpiderID_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref') per Chem/Drugbox validation (report [[Wikipedia talk:Wi |
m Removing from Category:GABAA receptor positive allosteric modulators in subcat using Cat-a-lot |
||
(32 intermediate revisions by 18 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
⚫ | |||
{{Drugbox |
|||
| |
|||
⚫ | |||
| IUPAC_name |
| IUPAC_name = 5-(1-cyclopent-2-enyl)-5-prop-2-enyl-1,3-<br>diazinane-2,4,6-trione |
||
| image |
| image = Cyclopal.svg |
||
| width |
| width = 120 |
||
<!--Clinical data--> |
|||
| tradename = |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| legal_CA = Schedule IV |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
<!--Pharmacokinetic data--> |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
<!--Identifiers--> |
|||
⚫ | |||
| CAS_supplemental = <br />302-34-1 ([[sodium]] salt) |
|||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = 2230XWG55Q |
|||
⚫ | |||
⚫ | |||
⚫ | |||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|||
⚫ | |||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
||
| ChemSpiderID = 6212 |
| ChemSpiderID = 6212 |
||
| InChI = 1/C12H14N2O3/c1-2-7-12(8-5-3-4-6-8)9(15)13-11(17)14-10(12)16/h2-3,5,8H,1,4,6-7H2,(H2,13,14,15,16,17) |
|||
<!--Chemical data--> |
|||
⚫ | |||
| smiles = O=C1NC(=O)NC(=O)C1(C2/C=C\CC2)C\C=C |
| smiles = O=C1NC(=O)NC(=O)C1(C2/C=C\CC2)C\C=C |
||
| InChIKey = XOVJAYNMQDTIJD-UHFFFAOYAJ |
|||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChI = 1S/C12H14N2O3/c1-2-7-12(8-5-3-4-6-8)9(15)13-11(17)14-10(12)16/h2-3,5,8H,1,4,6-7H2,(H2,13,14,15,16,17) |
| StdInChI = 1S/C12H14N2O3/c1-2-7-12(8-5-3-4-6-8)9(15)13-11(17)14-10(12)16/h2-3,5,8H,1,4,6-7H2,(H2,13,14,15,16,17) |
||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChIKey = XOVJAYNMQDTIJD-UHFFFAOYSA-N |
| StdInChIKey = XOVJAYNMQDTIJD-UHFFFAOYSA-N |
||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| molecular_weight = 234.251 g/mol |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| legal_CA = <!-- / Schedule I, II, III, IV, V, VI, VII, VIII --> |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
}} |
}} |
||
''' |
'''Cyclopentobarbital sodium''' ('''Cyclopal''', '''Dormisan''') is a [[barbiturate]] derivative invented in the 1940s.<ref name="MartinGodel2000">{{cite book | vauthors = Martin JR, Godel T, Hunkeler W, Jenck F, Moreau JL, Sleight AJ, Widmer U | chapter = Psychopharmacological agents. | title = Kirk-Othmer Encyclopedia of Chemical Technology | date = December 2000 | doi = 10.1002/0471238961.1619250313011820.a01 | isbn = 0471238961 }} </ref> It has [[sedative]] and [[anticonvulsant]] properties, and was used primarily as an anaesthetic in [[veterinary]] medicine.<ref>{{cite journal | vauthors = Vander Brook MJ, Cartland GF | title = A Pharmacologic Study of 5-Allyl-5-Cyclopentenyl Barbituric Acid (Cyclopal). | journal = Journal of Pharmacology and Experimental Therapeutics | date = 1944 | volume = 80 | issue = 2 | pages = 119–125 | citeseerx = 10.1.1.983.6071 }}</ref> Cyclopal is considered similar in effects to [[phenobarbital]] but lasts almost three times as long, and is considered a long-acting barbiturate with a fairly slow onset of action. |
||
== See also == |
|||
* [[Barbiturate]] |
|||
== References == |
== References == |
||
<references /> |
<references /> |
||
{{ |
{{Anesthetics}} |
||
{{GABAAR PAMs}} |
|||
{{barbiturates}} |
|||
[[Category:Allyl compounds]] |
|||
[[Category:General anesthetics]] |
|||
[[Category:Barbiturates]] |
[[Category:Barbiturates]] |
||
[[Category: |
[[Category:Cyclopentenes]] |
||
{{sedative-stub}} |